Ken Fisher’s Gossamer Bio GOSS Stock Holding History

Ken Fisher’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,000	Closed	-$18K	–	1210
2023 Q2	$18K	Buy	+15,000	New	+$18.7K	﹤0.01%	1085

Other funds holding GOSS

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Ken Fisher's GOSS Position: Q3 2023 in Review

Ken Fisher sold out of Gossamer Bio (GOSS) in Q3 2023, closing a stake of 15,000 shares — an estimated $18K sold.

Ken Fisher first reported a position in GOSS in Q2 2023 and held it in 1 quarter. The position peaked at $18K in Q2 2023. 95 funds tracked by Wall St. Rank hold GOSS as of Q3 2023.

Ken Fisher reported no remaining Gossamer Bio position as of Q3 2023 after selling out during the quarter.
Ken Fisher sold 15,000 Gossamer Bio shares in Q3 2023, an estimated $18K.
Ken Fisher first reported a position in Gossamer Bio in Q2 2023 and held it in 1 quarter.
Ken Fisher's Gossamer Bio position peaked at $18K in Q2 2023.
95 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2023.

Based on Fisher Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.